Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgery for gynecologic malignancies

I B Vergote1

  • 1Norwegian Radium Hospital, Department of Gynecologic Oncology, Montebello, Oslo.

Current Opinion in Oncology
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies.

Gynecologic oncology·2019
Same author

The rationale of opportunistic bilateral salpingectomies (OBS) during benign gynaecological and obstetric surgery: a consensus text of the Flemish Society of Obstetrics and Gynaecology (VVOG).

Facts, views & vision in ObGyn·2019
Same author

Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Methodology in plasma proteomic pattern experiments.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
Same author

Predicting the clinical behavior of ovarian cancer from gene expression profiles.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
Same author

A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

Gynecologic oncology·2006
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Cytoreductive surgery is vital for advanced ovarian cancer, but aggressive tumor removal is debated. Secondary cytoreduction may benefit select patients, while surgical staging and minimally invasive techniques are evolving in gynecologic oncology.

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology

Background:

  • Cytoreductive surgery is crucial for advanced ovarian cancer.
  • Recent research questions complete tumor removal in specific cases.
  • Evolving surgical techniques impact gynecologic cancer treatment.

Purpose of the Study:

  • To review current trends and controversies in gynecologic cancer surgery.
  • To assess the role of secondary cytoreduction and surgical staging.
  • To explore the potential of minimally invasive approaches like laparoscopy.

Main Methods:

  • Review of recent studies and clinical practices in gynecologic oncology.
  • Analysis of surgical staging for endometrial neoplasia.
  • Evaluation of techniques for cervical intraepithelial neoplasia and vulvar cancer.

Related Experiment Videos

  • Discussion of lymphadenectomy modifications and laparoscopic procedures.

    • Main Results:

    • Debate exists on the extent of cytoreduction in advanced ovarian cancer.
    • Secondary cytoreduction may improve survival in selected patients.
    • Surgical staging enhances endometrial cancer accuracy; clinical treatment impact is under investigation.
    • Modified dissections reduce morbidity for vulvar cancer.
    • Laparoscopic techniques are emerging in gynecologic cancer surgery.

    Conclusions:

    • The optimal extent of cytoreductive surgery requires further clarification.
    • Secondary cytoreduction offers potential survival benefits for specific patients.
    • Minimally invasive laparoscopic surgery is a developing area in gynecologic oncology with an uncertain future role.